# A Study to Characterize Diclofenac's Plasma and Knee Exposure After Application of Diclofenac Gel to the Knee of Subjects With Osteoarthritis That Have a Scheduled Arthroplasty

> **NCT03497039** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 47 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Diclofenac Diethylamine (DDEA) gel
- **OTHER:** Placebo gel

## Key facts

- **NCT ID:** NCT03497039
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-19
- **Primary completion:** 2019-03-01
- **Final completion:** 2019-03-01
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2020-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03497039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03497039, "A Study to Characterize Diclofenac's Plasma and Knee Exposure After Application of Diclofenac Gel to the Knee of Subjects With Osteoarthritis That Have a Scheduled Arthroplasty". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT03497039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*